AstraZeneca today reported a “very strong performance” for 2024 after total revenues rose 21% to $54.1 billion (£43.3 billion) and earnings lifted 19%. Chief executive Pascal Soriot added that the ...

Boost your returns and diversify your portfolio by investing in private markets. But does it live up to the hype? It can, if ...